All News Novartis AG Nyse

Equities

NVS

US66987V1098

Market Closed - Nyse Other stock markets 04:00:02 2024-04-30 pm EDT			5-day change	1st Jan Change
97.13 ^USD	+0.04%		-0.15%	-3.80%

10:19pm	FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	MT
05:51pm	FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	04:19pm	MT
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	11:51am	MT
Novartis : Q1 2024 impact and sustainability update	11:08am	PU
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	11:01am	MT
Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	07:00am	CI
Novartis target Morphosys multiplies losses - takeover schedule stands	Apr. 29	DP
Morphosys says takeover by Novartis on course after report of drug safety concern	Apr. 29	RE
European Commission authorises one of first ustekinumab biosimilars in Europe	Apr. 26	AQ
NOVARTIS AG : Receives a Buy rating from Jefferies	Apr. 26	ZD
BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating	Apr. 24	MT
Novartis Says New Malaria Drug Formulation Safe and Effective for Babies	Apr. 24	MT
Dpa-AFX Overview: COMPANIES from 24.04.2024 - 15:15	Apr. 24	DP
NOVARTIS AG : UBS reaffirms its Buy rating	Apr. 24	ZD
NOVARTIS AG : Deutsche Bank gives a Buy rating	Apr. 24	ZD
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump	Apr. 24	RE
Novartis: positive data for malaria treatment	Apr. 24	CF
NOVARTIS AG : JP Morgan remains Neutral	Apr. 24	ZD
Novartis, Medicines for Malaria Say Treatment for Babies Shows Efficacy	Apr. 24	DJ
Novartis Partnership Says New Malaria Drug for Babies Effective, Safe in Phase 2/3 Trial	Apr. 24	MT
Novartis Faces Lawsuit for Illegal Promotion of Asthma Drug as Preterm Labor Treatment	Apr. 24	MT